Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,193 | 52,309 | 82,425 | 45,556 | 32,190 |
| Receivables | 109,730 | 122,030 | 93,068 | 85,813 | 87,676 |
| Inventories | 94,080 | 89,231 | 104,668 | 60,605 | 53,504 |
| Income taxes - deferred | N/A | N/A | 2,249 | 2,280 | 2,312 |
| Other current assets | 516 | 516 | 1,132 | 1,132 | 1,132 |
| TOTAL | $274,011 | $280,245 | $303,429 | $206,667 | $189,771 |
| Non-Current Assets | |||||
| PPE Net | 216,902 | 209,508 | 213,686 | 175,045 | 176,997 |
| Intangibles | 293,608 | 289,675 | 232,540 | 133,607 | 132,825 |
| Other Non-Current Assets | 49,692 | 86,139 | 70,213 | 87,265 | 71,549 |
| TOTAL | $560,202 | $585,322 | $516,439 | $395,917 | $381,371 |
| Total Assets | $834,213 | $865,567 | $819,868 | $602,584 | $571,142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,843 | 15,591 | 15,129 | 455 | 413 |
| Accounts payable and accrued liabilities | 73,650 | 60,890 | 63,311 | 49,503 | 42,844 |
| Accrued Expenses | 571 | 7,897 | 585 | 509 | 651 |
| Other current liabilities | N/A | N/A | 2,098 | N/A | 0 |
| TOTAL | $101,598 | $99,096 | $99,284 | $60,559 | $53,756 |
| Non-Current Liabilities | |||||
| Long Term Debt | 373,725 | 373,692 | 344,373 | 201,651 | 200,493 |
| Deferred Revenues | 13,534 | 14,718 | 10,908 | 10,092 | 9,848 |
| Other Non-Current Liabilities | 51,887 | 86,195 | 72,315 | 91,349 | 75,018 |
| TOTAL | $445,697 | $479,248 | $431,847 | $293,000 | $275,511 |
| Total Liabilities | $547,295 | $578,344 | $531,131 | $353,559 | $329,267 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,703 | 35,829 | 35,502 | 35,453 | 33,118 |
| Common Shares | 413 | 411 | 410 | 387 | 386 |
| Retained earnings | 67,264 | 77,331 | 75,546 | 79,716 | 77,409 |
| Other shareholders' equity | -12,661 | -18,856 | -14,496 | -13,778 | -15,534 |
| TOTAL | $286,918 | $287,223 | $288,737 | $249,025 | $241,875 |
| Total Liabilities And Equity | $834,213 | $865,567 | $819,868 | $602,584 | $571,142 |